Premium
Hyperthermia associated with 3,4‐methylenedioxyethamphetamine (‘Eve’)
Author(s) -
TEHAN B.,
HARDERN R.,
BODENHAM A.
Publication year - 1993
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1993.tb07072.x
Subject(s) - medicine , hyperthermia , malignant hyperthermia , anesthesia
Summary A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), but subsequent toxicology revealed the presence of 3,4‐methylenedioxyethamphetamine (MDEA, ‘Eve’), its sister drug, in his blood. Subsequent in vitro testing for malignant hyperthermia proved to be negative.